Incidence, prevalence, and global burden of schizophrenia - data, with critical appraisal, from the Global Burden of Disease (GBD) 2019.
Solmi M, Seitidis G, Mavridis D, Correll CU, Dragioti E, Guimond S, Tuominen L, Dargél A, Carvalho AF, Fornaro M, Maes M, Monaco F, Song M, Il Shin J, Cortese S.
Mol Psychiatry. 2023 Dec;28(12):5319-5327. doi: 10.1038/s41380-023-02138-4. Epub 2023 Jul 27.
Genomic findings in schizophrenia and their implications.
Owen MJ, Legge SE, Rees E, Walters JTR, O'Donovan MC.
Mol Psychiatry. 2023 Sep;28(9):3638-3647. doi: 10.1038/s41380-023-02293-8. Epub 2023 Oct 18.
Schizophrenia risk from complex variation of complement component 4.
Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, Tooley K, Presumey J, Baum M, Van Doren V, Genovese G, Rose SA, Handsaker RE; Schizophrenia Working Group of the Psychiatric Genomics Consortium; Daly MJ, Carroll MC, Stevens B, McCarroll SA.
Nature. 2016 Feb 11;530(7589):177-83. doi: 10.1038/nature16549. Epub 2016 Jan 27.
Role of melatonin in schizophrenia.
Morera-Fumero AL, Abreu-Gonzalez P.
Int J Mol Sci. 2013 Apr 25;14(5):9037-50. doi: 10.3390/ijms14059037.
Epidemiology of schizophrenia.
Häfner H, an der Heiden W.
Can J Psychiatry. 1997 Mar;42(2):139-51. doi: 10.1177/070674379704200204.
Improving Current Treatments for Schizophrenia.
Maric NP, Jovicic MJ, Mihaljevic M, Miljevic C.
Drug Dev Res. 2016 Nov;77(7):357-367. doi: 10.1002/ddr.21337. Epub 2016 Sep 16.
Cystine/Glutamate Antiporter in Schizophrenia: From Molecular Mechanism to Novel Biomarker and Treatment.
Hung CC, Lin CH, Lane HY.
Int J Mol Sci. 2021 Sep 8;22(18):9718. doi: 10.3390/ijms22189718.
Association of histone modification with the development of schizophrenia.
Chen YZ, Zhu XM, Lv P, Hou XK, Pan Y, Li A, Du Z, Xuan JF, Guo X, Xing JX, Liu K, Yao J.
Biomed Pharmacother. 2024 Jun;175:116747. doi: 10.1016/j.biopha.2024.116747. Epub 2024 May 13.
Pharmacological interventions for prevention of weight gain in people with schizophrenia.
Agarwal SM, Stogios N, Ahsan ZA, Lockwood JT, Duncan MJ, Takeuchi H, Cohn T, Taylor VH, Remington G, Faulkner GEJ, Hahn M.
Cochrane Database Syst Rev. 2022 Oct 3;10(10):CD013337. doi: 10.1002/14651858.CD013337.pub2.
Multi-omics of human plasma reveals molecular features of dysregulated inflammation and accelerated aging in schizophrenia.
Campeau A, Mills RH, Stevens T, Rossitto LA, Meehan M, Dorrestein P, Daly R, Nguyen TT, Gonzalez DJ, Jeste DV, Hook V.
Mol Psychiatry. 2022 Feb;27(2):1217-1225. doi: 10.1038/s41380-021-01339-z. Epub 2021 Nov 5.
